About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Panel Discussion: Hereditary Risk Factors, Genetic Testing and Neoadjuvant Chemotherapy in Pancreatic Cancer/IO Side Effects in Lung Cancers
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Michel Velez
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Michel Velez
38 views
March 20, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Related Content
AUTOPLAY
ON
46:37
Albert Einstein College of Medicine
Screening for Pancreatic Cancer
Feat.
A. L. Lucas
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
08:34
Yale Cancer Center
NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …
Feat.
J. Lacy
53:42
PleXus Communications
Managing Women's Health in Menopause: Evolving Approaches for t…
Feat.
J. Simon,
T. Iyer,
A. Fiffick,
M. Minkin
53:40
Philadelphia County Medical Society
Current Status for the Early Detection of Pancreatic Cancer
Feat.
R. Brand
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
39:04
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Localized Pancreatic Cancer Controversial Cases: Panel Discussion
Feat.
M. Katz,
A. De Jesus-Acosta,
N. Zaidi,
J. He,
A. Narang,
T. Bekaii-Saab
07:53
Total Health
Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia
Feat.
D. Lin
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Pancreas Cancer
Feat.
T. Bekaii-Saab
06:28
Shubham Pant
FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…
17:05
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…
Feat.
A. Ohba
25:56
OncoAlert
Year in Review: Pancreatic Cancers
Feat.
M. Lewis
10:53
Yale Cancer Center
GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …
Feat.
J. Lacy
18:35
Rachna Shroff
Augmenting Standard Treatment Options in Pancreatic Cancer
23:02
Cleveland Clinic Taussig Cancer Institute
Pulmonary Complications of Checkpoint Inhibitor Therapy
Feat.
M. Smith
15:25
Scripps MD Anderson Cancer Center
Pancreatic Cancer Trials - Evolving Landscape and Treatment Guidance
Feat.
J. Hecht
10:13
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting
2023 ESMO WCGIC Insights: "Resectable Pancreatic Cancer - Neoad…
Feat.
T. Macarulla
15:57
Rush University Medical Center
Precision Medicine in Pancreatic Cancer: Treatment to Screening
Feat.
F. Bishehsari
